Factors for more favorable prognosis include O6-methylguanine-DNA methyltransferase promoter (MGMT) methylation and the presence of isocitrate dehydrogenase (IDH1) mutation, whereas increased age, poor patient performance status, increased number of lesions, and subtotal resection of tumor at surgery (compared with gross total resection) are associated with poor prognosis [8, 29, 32, 37, 40]. The gene discussed is MGMT; the disease is neoplasm.